Dawnrays Pharmaceutical Holdings Ltd operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Dawnrays Pharmaceutical Holdings Ltd with three other
companies in this sector in HONG KONG :
Beijing Tong Ren Tang Chinese Medicine Company Limited
sales of 1.32 billion Hong Kong Dollars [US$169.51 million]
of which 42%
was Hong Kong),
Jacobson Pharma Corporation Ltd
(1.57 billion Hong Kong Dollars [US$202.51 million]
of which 83%
was Generic drugs), and
Lee's Pharmaceutical Holdings Ltd
(1.22 billion Hong Kong Dollars [US$156.80 million]
of which 56%
was License-In Products).
During the year ended December of 2020, sales at
Dawnrays Pharmaceutical Holdings Ltd were HK$1.15 billion (US$148.70 million).
increase of 7.0%
versus 2019, when the company's sales were HK$1.08 billion.
The sales level in 2020 was fairly close to the level five years ago: in 2015, Dawnrays Pharmaceutical Holdings Ltd had sales
of HK$1.21 billion.
Sales of Finished Drugs saw an increase
that was more than double the company's growth rate: sales were up
14.5% in 2020, from
HK$810.44 million to HK$928.30 million.
Not all segments of Dawnrays Pharmaceutical Holdings Ltd experienced an increase in sales in 2020:
sales of Intermediates and Bulk Medicines fell 15.9% to HK$225.54 million.